TY - JOUR
T1 - Markers of cardiovascular disease risk in sleep-disordered breathing with or without comorbidities
T2 - the Nagahama study
AU - Nakatsuka, Yoshinari
AU - Murase, Kimihiko
AU - Matsumoto, Takeshi
AU - Tabara, Yasuharu
AU - Nakamoto, Isuzu
AU - Minami, Takuma
AU - Takahashi, Naomi
AU - Takeyama, Hirofumi
AU - Kanai, Osamu
AU - Hamada, Satoshi
AU - Tanizawa, Kiminobu
AU - Handa, Tomohiro
AU - Wakamura, Tomoko
AU - Komenami, Naoko
AU - Morita, Satoshi
AU - Nakayama, Takeo
AU - Hirai, Toyohiro
AU - Matsuda, Fumihiko
AU - Chin, Kazuo
N1 - Funding Information:
All authors have seen and approved the manuscript. Work for this study was performed at Department of Respiratory Care and Sleep Control Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan. This work was supported by a University Grant, a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology in Japan, the Center of Innovation Program, and the Global University Project from Japan Science and Technology Agency (JSPS KAKENHI), Japan Agency for Medical Research and Development under grant numbers JP16dk0207006, JP16ek0109070, JP17ek0109283, JP16ek0109196, JP16kk0205008, and JP17ek0210096, grants from the Ministry of Education, Culture, Sports, Science and Technology in Japan (JSPS KAKENHI 26293198 and 17H04182), the Intractable Respiratory Diseases and Pulmonary Hypertension Research Group from the Ministry of Health, Labor and Welfare in Japan (H29-intractable diseases-general-027), and Health, Labour and Welfare Sciences Research Grants, Research on Region Medical (H28-iryo-ippan-016 and H30-iryo-ippan-009). This study was supported by a university grant, the Center of Innovation Program, the Global University Project, and a Grant-in-Aid for Scientific Research (25293141, 26670313, 26293198, 17H04182, 17H04126, 17H04123, 18K18450) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Practical Research Project for Rare/Intractable Diseases (ek0109070, ek0109070, ek0109196, ek0109348), the Comprehensive Research on Aging and Health Science Research Grants for Dementia R&D (dk0207006, dk0207027), the Program for an Integrated Database of Clinical and Genomic Information (kk0205008), the Practical Research Project for Lifestyle-related Diseases including Cardiovascular Diseases and Diabetes Mellitus (ek0210066, ek0210096, ek0210116), and the Research Program for Health
Funding Information:
The authors express gratitude to the Nagahama City Office and the nonprofit organization Zeroji Club for their assistance in conducting the Nagahama study. They also thank M. Daikoku, Y. Kohdono, S. Tamura, and T. Toki (Department of Respiratory Care and Sleep Control Medicine, Graduate School of Medicine, Kyoto University) for their secretarial work.
Publisher Copyright:
© 2021 American Academy of Sleep Medicine. All rights reserved.
PY - 2021/12
Y1 - 2021/12
N2 - Study Objectives: Whether the association between sleep-disordered breathing (SDB) and cardiovascular disease is independent of comorbid risk factors for cardiovascular disease is controversial. The objective of this study was to elucidate whether the association between SDB severity and the surrogate markers of cardiovascular disease events differs in relation to the number of comorbidities. Methods: This cross-sectional study included 7,731 participants. Severity of SDB was determined by the oxygen desaturation index adjusted by actigraph-measured objective sleep time. Participants were stratified according to SDB severity and the number of comorbidities (hypertension, diabetes, dyslipidemia, and obesity), and the associations between the maximum value of intima-media thickness of the common carotid artery (CCA-IMT-max), brachial-ankle pulse wave velocity, and cardio-ankle vascular index were evaluated. Results: Among participants with no risk factors, CCA-IMT-max increased according to SDB severity (n = 1022, P < .0001). Even after matching the background, the median CCA-IMT-max value was 14% higher in moderate-severe SDB patients than those without SDB (n = 45 in each group, P = .020). The difference was not significant for brachial-ankle pulse wave velocity and cardio-ankle vascular index. On the other hand, a significant difference in CCA-IMT-max was not found in those with multiple comorbidities. Consistently, multiple regression analysis revealed an independent association between CCA-IMT-max and moderate-severe SDB for all study participants (b: 0.0222, 95% confidence interval: 0.0039-0.0405, P = .017), but the association was not significant for stratified participants with multiple comorbidities. Conclusions: SDB severity is associated with the CCA-IMT-max level, but the independent association becomes weaker for those with multiple comorbidities.
AB - Study Objectives: Whether the association between sleep-disordered breathing (SDB) and cardiovascular disease is independent of comorbid risk factors for cardiovascular disease is controversial. The objective of this study was to elucidate whether the association between SDB severity and the surrogate markers of cardiovascular disease events differs in relation to the number of comorbidities. Methods: This cross-sectional study included 7,731 participants. Severity of SDB was determined by the oxygen desaturation index adjusted by actigraph-measured objective sleep time. Participants were stratified according to SDB severity and the number of comorbidities (hypertension, diabetes, dyslipidemia, and obesity), and the associations between the maximum value of intima-media thickness of the common carotid artery (CCA-IMT-max), brachial-ankle pulse wave velocity, and cardio-ankle vascular index were evaluated. Results: Among participants with no risk factors, CCA-IMT-max increased according to SDB severity (n = 1022, P < .0001). Even after matching the background, the median CCA-IMT-max value was 14% higher in moderate-severe SDB patients than those without SDB (n = 45 in each group, P = .020). The difference was not significant for brachial-ankle pulse wave velocity and cardio-ankle vascular index. On the other hand, a significant difference in CCA-IMT-max was not found in those with multiple comorbidities. Consistently, multiple regression analysis revealed an independent association between CCA-IMT-max and moderate-severe SDB for all study participants (b: 0.0222, 95% confidence interval: 0.0039-0.0405, P = .017), but the association was not significant for stratified participants with multiple comorbidities. Conclusions: SDB severity is associated with the CCA-IMT-max level, but the independent association becomes weaker for those with multiple comorbidities.
KW - cardiovascular diseases
KW - clinical epidemiology
KW - sleep apnea
UR - http://www.scopus.com/inward/record.url?scp=85122490006&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85122490006&partnerID=8YFLogxK
U2 - 10.5664/jcsm.9460
DO - 10.5664/jcsm.9460
M3 - Article
C2 - 34170234
AN - SCOPUS:85122490006
SN - 1550-9389
VL - 17
SP - 2467
EP - 2475
JO - Journal of Clinical Sleep Medicine
JF - Journal of Clinical Sleep Medicine
IS - 12
ER -